Mark Holtzapple – Trademark Portfolio

Entity Type: 01

Mark Holtzapple holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NOZESEAL. The owner is based in College Station, TX.

8601 Rosewood Dr

College Station, TX 77845

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Mark Holtzapple's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Mark Holtzapple have?

Mark Holtzapple has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Mark Holtzapple file in?

Mark Holtzapple files trademarks across 3 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 5 (Pharmaceuticals), Class 12 (Vehicles). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.

What are Mark Holtzapple's most well-known trademarks?

Mark Holtzapple's registered trademark portfolio includes well-known marks such as NOZESEAL. These are among 1 currently registered trademark in the portfolio.

What is Mark Holtzapple's trademark registration success rate?

Mark Holtzapple has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.